Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 57, 2404-2409, June 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyle, C. C.
Right arrow Articles by Hickman, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyle, C. C.
Right arrow Articles by Hickman, J. A.

Toxin-induced Increase in Survival Factor Receptors: Modulation of the Threshold for Apoptosis1

Catherine C. Boyle and John A. Hickman2

School of Biological Sciences, G38 Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT, United Kingdom

The threshold at which toxins induce cell death is thought to directly relate to the amount of injury sustained. We show that the threshold at which a cell initiates toxin-induced death may vary in response to changes in the trophic environment. Treatment of Rat-1 fibroblasts with 50–175 mM dimethylformamide (DMF) induced cell death by apoptosis. Addition of insulin-like growth factor 1 (IGF-1; 100 ng/ml) and/or overexpression of the IGF-1 receptor (IGF-1R) attenuated the cytotoxicity of DMF. Furthermore, 95–99% of cells were protected from DMF-induced apoptosis if cells were pretreated with platelet-derived growth factor (5 ng/ml) for 16 h before treatment with DMF in the presence of IGF-1. Platelet-derived growth factor induced the expression of IGF-1R mRNA. The ability of cells to proliferate and survive after a 24-h treatment with DMF was determined by colony formation; whereas treatment with concentrations of >130 mM DMF reduced cellular survival, exposure to concentrations of <130 mM unexpectedly increased the colony-forming ability of treated cells when compared to that of controls. Treatment of Rat-1 fibroblasts with 75 and 130 mM DMF induced IGF-1R mRNA as determined by reverse transcription-PCR analysis. Serum withdrawal also transiently increased the expression of IGF-1R mRNA in Rat-1 fibroblasts. These results show that cells can actively adapt to pathological and physiological stress by up-regulating receptors that provide signals for cellular survival. We suggest that the threshold for toxin-induced apoptosis is determined not only by the extent of cytotoxic damage but also by the trophic environment and the ability of a cell to modulate survival signals that attenuate toxicity.

1 C. C. B. is the recipient of a Wellcome Trust Research Fellowship in Molecular Toxicology. J. A. H. acknowledges the support of the Cancer Research Campaign and Zeneca Pharmaceuticals.

2 To whom requests for reprints should be addressed.

Received 12/17/96. Accepted 4/22/97.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. B. Salmon, S. Murakami, A. Bartke, J. Kopchick, K. Yasumura, and R. A. Miller
Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress
Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E23 - E29.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. D. Cohen, D. A. Baker, C. Soderstrom, G. Tkalcevic, A. M. Rossi, P. E. Miller, M. W. Tengowski, F. Wang, A. Gualberto, J. S. Beebe, et al.
Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti-Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871
Clin. Cancer Res., March 1, 2005; 11(5): 2063 - 2073.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
W. BURSCH, A. ELLINGER, CH. GERNER, U. FROHWEIN, and R. SCHULTE-HERMANN
Programmed Cell Death (PCD): Apoptosis, Autophagic PCD, or Others?
Ann. N.Y. Acad. Sci., December 1, 2000; 926(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
W Bursch, K Hochegger, L Torok, B Marian, A Ellinger, and R. Hermann
Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments
J. Cell Sci., January 4, 2000; 113(7): 1189 - 1198.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
S. Chevalier and R.A. Roberts
G1-arrested FaO cells re-enter the cell cycle upon stimulation with the rodent non-genotoxic hepatocarcinogen nafenopin
Carcinogenesis, July 1, 1999; 20(7): 1209 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S Chevalier, N Macdonald, and R. Roberts
Induction of DNA replication by peroxisome proliferators is independent of both tumour necrosis factor (alpha) priming and EGF-receptor tyrosine kinase activity
J. Cell Sci., January 12, 1999; 112(24): 4785 - 4791.
[Abstract] [PDF]


Home page
DevelopmentHome page
S. Moallem and B. Hales
The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations
Development, January 8, 1998; 125(16): 3225 - 3234.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1997 by the American Association for Cancer Research.